Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

The Impact of Ischemic Time on the Predictive Value of High-Sensitivity C-Reactive Protein in ST-Segment Elevation Myocardial Infarction Patients Treated by Primary Percutaneous Coronary Intervention.

Kim KH, Kim W, Kang WY, Hwang SH, Cho SC, Kim W, Jeong MH; Other Korean Working Group in Myocardial Infarction Investigators..

Korean Circ J. 2013 Oct;43(10):664-73. doi: 10.4070/kcj.2013.43.10.664. Epub 2013 Oct 30.

2.

High sensitive C-reactive protein and the risk of acute kidney injury among ST elevation myocardial infarction patients undergoing primary percutaneous intervention.

Shacham Y, Leshem-Rubinow E, Steinvil A, Keren G, Roth A, Arbel Y.

Clin Exp Nephrol. 2015 Oct;19(5):838-43. doi: 10.1007/s10157-014-1071-1. Epub 2014 Dec 10.

PMID:
25492251
3.

Usefulness of preprocedure high-sensitivity C-reactive protein to predict death, recurrent myocardial infarction, and stent thrombosis according to stent type in patients with ST-segment elevation myocardial infarction randomized to bare metal or drug-eluting stenting during primary percutaneous coronary intervention.

Schoos MM, Kelbæk H, Kofoed KF, Køber L, Kløvgaard L, Helqvist S, Engstrøm T, Saunamäki K, Jørgensen E, Holmvang L, Clemmensen P.

Am J Cardiol. 2011 Jun 1;107(11):1597-603. doi: 10.1016/j.amjcard.2011.01.042. Epub 2011 Mar 23.

PMID:
21439539
4.

High-sensitivity C-reactive protein predicts contrast-induced nephropathy after primary percutaneous coronary intervention.

Liu Y, Tan N, Zhou YL, Chen YY, Chen JY, Chen J, Luo JF.

J Nephrol. 2012 May-Jun;25(3):332-40. doi: 10.5301/jn.5000007.

PMID:
21928234
5.

Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneous coronary intervention.

Ortolani P, Marzocchi A, Marrozzini C, Palmerini T, Saia F, Taglieri N, Baldazzi F, Silenzi S, Bacchi-Reggiani ML, Guastaroba P, Grilli R, Branzi A.

Eur Heart J. 2008 May;29(10):1241-9. Epub 2007 Aug 31.

PMID:
17766280
6.

[The significance of admission hs-CRP in patients undergoing primary percutaneous intervention for acute myocardial infarction].

Cağli KE, Topaloğlu S, Aras D, Günel EN, Ozlü MF, Uygur B, Baysal E, Sen N.

Turk Kardiyol Dern Ars. 2009 Jan;37(1):19-25. Turkish.

7.

[Association between high-sensitivity C-reactive protein and contrast-induced nephropathy after primary percutaneous coronary intervention].

He YT, Tan N, Liu YH, Chen SQ, Liu Y, Huang SJ, Yang DH, Ye P, Ran P.

Zhonghua Xin Xue Guan Bing Za Zhi. 2013 May;41(5):394-8. Chinese.

PMID:
24021122
8.

The impact of admission C-reactive protein levels on the development of poor myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarction.

Celik T, Iyisoy A, Kursaklioglu H, Turhan H, Kilic S, Kose S, Amasyali B, Isik E.

Coron Artery Dis. 2005 Aug;16(5):293-9.

PMID:
16000887
9.

Changes in BNP, hs-CRP and TIMI risk index with addition of tirofiban during primary percutaneous coronary intervention for acute STEMI: a prospective observational cohort study.

Kurt IH, Demirkol S, Ünal I, Batur MK.

Anadolu Kardiyol Derg. 2012 Mar;12(2):107-14. doi: 10.5152/akd.2012.035. Epub 2012 Jan 26.

10.

Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.

Delhaye C, Sudre A, Lemesle G, Maréchaux S, Broucqsault D, Hennache B, Bauters C, Lablanche JM.

Cardiovasc Revasc Med. 2009 Jul-Sep;10(3):144-50. doi: 10.1016/j.carrev.2009.01.005.

PMID:
19595394
11.

Diagnostic value of biohumoral markers of necrosis and inflammation in patients with right ventricular myocardial infarction.

Orozović V, Rafajlovski S, Gligić B, Miailović Z, Obradović S, Ratković N, Djenić N, Baskot B.

Prilozi. 2007 Jul;28(1):23-38.

PMID:
17921916
12.

Clinical and angiographic correlation of high-sensitivity C-reactive protein with acute ST elevation myocardial infarction.

Tanveer S, Banu S, Jabir NR, Khan MS, Ashraf GM, Manjunath NC, Tabrez S.

Exp Ther Med. 2016 Dec;12(6):4089-4098. doi: 10.3892/etm.2016.3882. Epub 2016 Nov 8.

13.

Oxidized Low Density Lipoprotein and High Sensitive C-Reactive Protein in Non-Diabetic, Pre-Diabetic and Diabetic Patients in the Acute Phase of the First Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention.

Trifunović D, Stanković S, Marinković J, Banović M, Đukanović N, Vasović O, Vujisić-Tešić B, Petrović M, Stepanović J, Đorđević-Dikić A, Beleslin B, Nedeljković I, Tešić M, Ostojić M.

J Med Biochem. 2015 Apr;34(2):160-169. doi: 10.2478/jomb-2014-0037. Epub 2015 Mar 3.

14.

Renal Dysfunction and hsCRP Predict Long-term Outcomes of Percutaneous Coronary Intervention in Acute Myocardial Infarction.

Wang CH, Zhang SY, Fang Q, Shen ZJ, Fan ZJ, Jin XF, Zeng Y, Liu ZY, Xie HZ.

Am J Med Sci. 2015 May;349(5):413-20. doi: 10.1097/MAJ.0000000000000430.

PMID:
25782335
15.

Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention.

Akpek M, Kaya MG, Lam YY, Sahin O, Elcik D, Celik T, Ergin A, Gibson CM.

Am J Cardiol. 2012 Sep 1;110(5):621-7. doi: 10.1016/j.amjcard.2012.04.041. Epub 2012 May 18.

PMID:
22608360
16.

Prognostic value of different serum biomarkers for left ventricular remodelling after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.

Urbano-Moral JA, Lopez-Haldon JE, Fernandez M, Mancha F, Sanchez A, Rodriguez-Puras MJ, Villa M, Lopez-Pardo F, Diaz de la Llera L, Valle JI, Martinez A.

Heart. 2012 Aug;98(15):1153-9. doi: 10.1136/heartjnl-2012-301636. Epub 2012 May 9.

PMID:
22572051
17.

Predictors of coronary artery aneurysm after stent implantation in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.

Karabay CY, Kocabay G, Guler A, Oduncu V, Akgun T, Kalayci A, Kılıcgedik A, Tasar O, Kalkan S, Erkol A, Izgi A, Esen AM, Kirma C.

Int J Cardiovasc Imaging. 2014 Dec;30(8):1435-44. doi: 10.1007/s10554-014-0503-z. Epub 2014 Jul 23.

PMID:
25053515
18.

Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Celık T, Balta S, Demır M, Yıldırım AO, Kaya MG, Ozturk C, Demırkol S, Unlu M, Kılıc S, Aydın İ, Iyısoy A.

Cardiol J. 2016;23(1):84-92. doi: 10.5603/CJ.a2015.0070. Epub 2015 Oct 27.

20.

Predictive value of GRACE risk scores for contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction before undergoing primary percutaneous coronary intervention.

Liu YH, Liu Y, Tan N, Chen JY, Chen J, Chen SH, He YT, Ran P, Ye P, Li Y.

Int Urol Nephrol. 2014 Feb;46(2):417-26. doi: 10.1007/s11255-013-0598-5. Epub 2013 Nov 22.

PMID:
24265037

Supplemental Content

Support Center